<DOC>
	<DOCNO>NCT02489305</DOCNO>
	<brief_summary>The purpose study identify self-reported objective measure relate mood parameter predict near-term relapse ( within 1 month another identified time point meeting criterion relapse ) early symptomatic change indicative relapse prodrome major depressive disorder ( MDD ) .</brief_summary>
	<brief_title>Study Evaluate Potential Predictors Relapse Participants With Major Depressive Disorder ( MDD )</brief_title>
	<detailed_description>This prospective , multicenter , longitudinal , single-cohort , observational study participant MDD respond , continue respond receive , oral antidepressant treatment regimen . The study consist 2 part : screen phase 2 week , observational phase variable duration .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Participants must meet Diagnostic Statistical Manual Mental Disorders5th edition ( DSM5 ) criteria diagnosis nonpsychotic MDD within past 2 year ( , start current major depressive episode ( MDE ) must less equal 24 Months screen ) , confirm use MINI International Neuropsychiatric Interview ( MINI DSM5 ) . MDD must recurrent , rather single episode In current MDE , participant must respond , must continue receive respond , oral antidepressant treatment regimen ( give adequate dosage duration base Massachusetts General Hospital Antidepressant Treatment Response Questionnaire ) , within past 3 month . A change oral antidepressant treatment regimen since time achieve response current episode allow Participants must Montgomery Asberg Depression Rating Scale total score less equal 14 Participant must willing able complete selfreported assessment via studyspecific smartphone , must willing wear wrist actigraphy device duration study Participant follow DSM5 psychiatric diagnosis : MDD psychotic feature ( lifetime ) , bipolar disorder ( include lifetime diagnosis ) , schizophrenia , schizoaffective disorder Participant history drug alcohol use , severity least moderate severe , accord DSM5 criterion , within 6 month screen Participant currently receive receive vagal nerve stimulation ( VNS ) , electroconvulsive therapy ( ECT ) , transcranial magnetic stimulation ( TMS ) deep brain stimulation ( DBS ) current MDE Participant currently receive stimulant , anticonvulsant , mood stabilizer treatment MDD Participant woman pregnant , plan become pregnant , enrol study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Depressive Disorder , Major</keyword>
	<keyword>Depression</keyword>
	<keyword>Anti-Depressant</keyword>
	<keyword>Observational</keyword>
</DOC>